Di Kasimova posts about week one on Mounjaro, framing it as her own experience rather than medical advice and telling viewers to check with a doctor.
Recap by typeshit. Post by @di_kasimova on Instagram.
General exercise advice aimed at GLP-1 users, shared on Facebook with no study or expert named in the material available.
Gilead takes global rights to the Shanghai biotech's program, led by HCXT-2001, an oral peptide that could compete with injected IBD drugs.
A Facebook promo for a podcast episode on the ripple effects of GLP-1 consumers across businesses. Few details beyond the pitch.
10:49
xitsnemox posts a short check-in from week 14 on oral Wegovy, two weeks after stepping up to the 25mg tablet. A personal account, not medical advice.
The interim policy would ease enforcement on compounding pharmacies making select peptides, per two people familiar with it. FDA scientists had cited thin human safety data.
An educational social clip that says it doesn't sell peptides or give dosing. Details beyond the disclaimer are thin.
Loading…